Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab.
Qing M, Zhou T, Perova T, Abraham Y, Sweeney C, Krevvata M, Zhang X, Qi M, Gao G, Kim TM, Yao M, Cho SG, Eom HS, Lim ST, Yeh SP, Kwong YL, Yoon DH, Kim JS, Kim WS, Zhou L, Attar R, Verona RI.
Qing M, et al. Among authors: eom hs.
Ann Hematol. 2024 Jan 18. doi: 10.1007/s00277-023-05603-w. Online ahead of print.
Ann Hematol. 2024.
PMID: 38233570